|Articles|June 1, 2003
- BioPharm International-06-02-2003
- Volume 2003 Supplement
- Issue 1
Part 4: Culture Media, Biotechnology Products, and Vaccines
Author(s)Gail Sofer
by Gail Sofer, BioReliance
Advertisement
Articles in this issue
over 22 years ago
Part 1: Skin, Bone, and Cellsover 22 years ago
BioPharm International's Virus Inactivation Series: A Prefaceover 22 years ago
Inactivation of Viruses: An Introduction to the Seriesover 22 years ago
Part 6: Inactivation Methods Grouped by Virusover 22 years ago
Part 5: Disinfectionover 22 years ago
Part 2: Red Blood Cells and PlateletsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Analytics, Automation, and Quality Driving the Next Era of Drug Development
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
4
Trends in Formulation eBook October 2025
5